{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:19:33Z","timestamp":1790882373827,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medizinische Hochschule Brandenburg CAMPUS GmbH"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Introduction<\/jats:title>\n            <jats:p>Cerebral metastases (CM) are the most common intracranial neoplasms, significantly impacting patient quality-of-life. Despite advancements in diagnostics and therapeutics, the burden remains high. This study evaluates inpatient management, palliative care use, and mortality outcomes for CM patients in German hospitals in 2022.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A cross-sectional analysis was conducted on 71,787 inpatient cases involving adult CM and leptomeningeal malignancies patients in German hospitals in 2022. Data submitted by hospitals according to \u00a721 of the Hospital Remuneration Act were analyzed, focusing on demographic data, primary tumor types, treatment methods, participation in palliative care, and discharge outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Among the 71,787 cases, 53.4% were patients aged 65\u00a0years or older. Malignant lung tumors were present in 61.6% of cases, followed by breast malignancies (12%) and malignant melanoma and diffuse diffuse large B-cell lymphoma (each 6.4%). Specialized inpatient palliative care (SIPC) was provided in 14.8% (10,636 cases), with 85.2% not receiving such care. Hospital mortality was 13.1% (9413 cases), with 42.2% of these involving patients who received SIPC. Discharge outcomes included discharge home (72.7%), transfers to other hospitals (7.1%), rehabilitation facilities (0.4%), nursing facilities (2%), and hospices (2.4%).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Despite treatment advances, high mortality rates for CM patients persist, underscoring the need for palliative care integration and comprehensive training to enhance patient outcomes. Health care planning is a growing topic, our study establishes a benchmark for CM care in German hospitals, revealing a significant number of patients not receiving SIPC. This research can inform future healthcare strategies in neuro-oncology.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s11060-024-04928-4","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T12:14:37Z","timestamp":1744373677000},"page":"37-48","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Epidemiology and palliative care of in-patient cerebral metastases cases in Germany"],"prefix":"10.1007","volume":"173","author":[{"given":"Larissa","family":"Fink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"von Sa\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidrun","family":"Golla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Voltz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Muehlensiepen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph J.","family":"Ploner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp J.","family":"Slotty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitt","family":"van Oorschot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander B.","family":"Kowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel A.","family":"Kamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,11]]},"reference":[{"key":"4928_CR1","doi-asserted-by":"publisher","DOI":"10.1080\/13520806.1972.11759235","author":"C Saunders","year":"1975","unstructured":"Saunders C (1975) The care of the dying patient and his family. Doc Med Ethics. https:\/\/doi.org\/10.1080\/13520806.1972.11759235","journal-title":"Doc Med Ethics"},{"key":"4928_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1200\/JCO.2011.41.0639","volume":"31","author":"R Soffietti","year":"2013","unstructured":"Soffietti R, Kocher M, Abacioglu UM, Villa S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann RD, Carrie C, Ben Hassel M, Kouri M, Valeinis E, van den Berge D, Mueller RP, Tridello G, Collette L, Bottomley A (2013) A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results. J Clin Oncol 31:65\u201372. https:\/\/doi.org\/10.1200\/JCO.2011.41.0639","journal-title":"J Clin Oncol"},{"key":"4928_CR3","doi-asserted-by":"publisher","first-page":"15911","DOI":"10.1007\/s00432-023-05338-1","volume":"149","author":"MA Kamp","year":"2023","unstructured":"Kamp MA, von Sass C, Januzi D, Dibue M, Libourius K, Lawson McLean AC, Baumgarten P, Lawson McLean A, Dinc N, Senft CA (2023) Frequency of social burden and underage children in neuro-oncological patients. J Cancer Res Clin Oncol 149:15911\u201315922. https:\/\/doi.org\/10.1007\/s00432-023-05338-1","journal-title":"J Cancer Res Clin Oncol"},{"key":"4928_CR4","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1200\/JCO.2004.12.149","volume":"22","author":"JS Barnholtz-Sloan","year":"2004","unstructured":"Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE (2004) Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol 22:2865\u20132872. https:\/\/doi.org\/10.1200\/JCO.2004.12.149","journal-title":"J Clin Oncol"},{"key":"4928_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/B978-0-12-811161-1.00002-5","volume":"149","author":"QT Ostrom","year":"2018","unstructured":"Ostrom QT, Wright CH, Barnholtz-Sloan JS (2018) Brain metastases: epidemiology. Handb Clin Neurol 149:27\u201342. https:\/\/doi.org\/10.1016\/B978-0-12-811161-1.00002-5","journal-title":"Handb Clin Neurol"},{"key":"4928_CR6","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1007\/s13311-022-01312-w","volume":"19","author":"K Singh","year":"2022","unstructured":"Singh K, Saxena S, Khosla AA, McDermott MW, Kotecha RR, Ahluwalia MS (2022) Update on the management of brain metastasis. Neurotherapeutics 19:1772\u20131781. https:\/\/doi.org\/10.1007\/s13311-022-01312-w","journal-title":"Neurotherapeutics"},{"key":"4928_CR7","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1093\/neuonc\/noab101","volume":"23","author":"N Lamba","year":"2021","unstructured":"Lamba N, Wen PY, Aizer AA (2021) Epidemiology of brain metastases and leptomeningeal disease. Neuro Oncol 23:1447\u20131456. https:\/\/doi.org\/10.1093\/neuonc\/noab101","journal-title":"Neuro Oncol"},{"key":"4928_CR8","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1056\/nejm199002223220802","volume":"322","author":"RA Patchell","year":"1990","unstructured":"Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, Markesbery WR, Macdonald JS, Young B (1990) A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322:494\u2013500. https:\/\/doi.org\/10.1056\/nejm199002223220802","journal-title":"N Engl J Med"},{"key":"4928_CR9","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1200\/JCO.2010.30.1655","volume":"29","author":"M Kocher","year":"2011","unstructured":"Kocher M, Soffietti R, Abacioglu U, Villa S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann RD, Carrie C, Ben Hassel M, Kouri M, Valeinis E, van den Berge D, Collette S, Collette L, Mueller RP (2011) Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952\u201326001 study. J Clin Oncol 29:134\u2013141. https:\/\/doi.org\/10.1200\/JCO.2010.30.1655","journal-title":"J Clin Oncol"},{"key":"4928_CR10","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S1470-2045(17)30441-2","volume":"18","author":"PD Brown","year":"2017","unstructured":"Brown PD, Ballman KV, Cerhan JH, Anderson SK, Carrero XW, Whitton AC, Greenspoon J, Parney IF, Laack NNI, Ashman JB, Bahary JP, Hadjipanayis CG, Urbanic JJ, Barker FG 2nd, Farace E, Khuntia D, Giannini C, Buckner JC, Galanis E, Roberge D (2017) Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C\/CEC.3): a multicentre, randomised, controlled, phase 3 trial. Lancet Oncol 18:1049\u20131060. https:\/\/doi.org\/10.1016\/S1470-2045(17)30441-2","journal-title":"Lancet Oncol"},{"key":"4928_CR11","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.1200\/JCO.20.01255","volume":"38","author":"PW Sperduto","year":"2020","unstructured":"Sperduto PW, Mesko S, Li J, Cagney D, Aizer A, Lin NU, Nesbit E, Kruser TJ, Chan J, Braunstein S, Lee J, Kirkpatrick JP, Breen W, Brown PD, Shi D, Shih HA, Soliman H, Sahgal A, Shanley R, Sperduto WA, Lou E, Everett A, Boggs DH, Masucci L, Roberge D, Remick J, Plichta K, Buatti JM, Jain S, Gaspar LE, Wu CC, Wang TJC, Bryant J, Chuong M, An Y, Chiang V, Nakano T, Aoyama H, Mehta MP (2020) Survival in patients with brain metastases: summary report on the updated diagnosis-specific graded prognostic assessment and definition of the eligibility quotient. J Clin Oncol 38:3773\u20133784. https:\/\/doi.org\/10.1200\/JCO.20.01255","journal-title":"J Clin Oncol"},{"key":"4928_CR12","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S1474-4422(23)00129-1","volume":"22","author":"BM Kluger","year":"2023","unstructured":"Kluger BM, Hudson P, Hanson LC, Buzgova R, Creutzfeldt CJ, Gursahani R, Sumrall M, White C, Oliver DJ, Pantilat SZ, Miyasaki J (2023) Palliative care to support the needs of adults with neurological disease. Lancet Neurol 22:619\u2013631. https:\/\/doi.org\/10.1016\/S1474-4422(23)00129-1","journal-title":"Lancet Neurol"},{"key":"4928_CR13","doi-asserted-by":"publisher","first-page":"31650","DOI":"10.18632\/oncotarget.25833","volume":"9","author":"M Rapp","year":"2018","unstructured":"Rapp M, Schipmann S, Hoffmann K, Wiewrodt R, Steiger H-J, Kamp M, Stummer W, Wiewrodt D, Sabel M (2018) Impact of distress screening algorithm for psycho-oncological needs in neurosurgical patients. Oncotarget 9:31650","journal-title":"Oncotarget"},{"key":"4928_CR14","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1007\/s00761-023-01417-7","volume":"29","author":"B van Oorschot","year":"2023","unstructured":"van Oorschot B, Jentschke E, Kessler AF, Wittig A, Kamp M (2023) Dringende Notwendigkeit f\u00fcr strukturiertes Symptom- und Belastungsscreening bei Patienten mit prim\u00e4ren und sekund\u00e4ren Hirntumoren. Die Onkologie 29:984\u2013990. https:\/\/doi.org\/10.1007\/s00761-023-01417-7","journal-title":"Die Onkologie"},{"key":"4928_CR15","unstructured":"World Health Organization (2002) WHO definition of palliative care. http:\/\/www.who.int\/cancer\/palliative\/definition\/en\/. Accessed 16 Sep 2019"},{"key":"4928_CR16","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, Initiative S (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370:1453\u20131457. https:\/\/doi.org\/10.1016\/S0140-6736(07)61602-X","journal-title":"Lancet"},{"key":"4928_CR17","unstructured":"Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte (BfArM) (2024) Internationale statistische Klassifikation der Krankheiten und verwandter Gesundheitsprobleme, 10. Revision, German Modification, Version 2023. https:\/\/klassifikationen.bfarm.de\/icd-10-gm\/kode-suche\/htmlgm2023\/index.htm. Accessed 21 Feb 2024"},{"key":"4928_CR18","unstructured":"Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte (BfArM) (2024) OPS Version 2023. Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte (BfArM). https:\/\/klassifikationen.bfarm.de\/ops\/kode-suche\/htmlops2023\/index.htm. Accessed 16 Jun 2024"},{"key":"4928_CR19","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","volume":"47","author":"M Charlson","year":"1994","unstructured":"Charlson M, Szatrowski TP, Peterson J, Gold J (1994) Validation of a combined comorbidity index. J Clin Epidemiol 47:1245\u20131251. https:\/\/doi.org\/10.1016\/0895-4356(94)90129-5","journal-title":"J Clin Epidemiol"},{"key":"4928_CR20","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00066-023-02123-4","volume":"200","author":"M Hugel","year":"2024","unstructured":"Hugel M, Stohr J, Kuhnt T, Nagler F, Papsdorf K, Klagges S, Hambsch P, Guresir E, Nicolay NH, Seidel C (2024) Long-term survival in patients with brain metastases-clinical characterization of a rare scenario. Strahlenther Onkol 200:335\u2013345. https:\/\/doi.org\/10.1007\/s00066-023-02123-4","journal-title":"Strahlenther Onkol"},{"key":"4928_CR21","doi-asserted-by":"publisher","first-page":"66776","DOI":"10.18632\/oncotarget.11488","volume":"7","author":"MA Kamp","year":"2016","unstructured":"Kamp MA, Fischer I, Buhner J, Turowski B, Cornelius JF, Steiger HJ, Rapp M, Slotty PJ, Sabel M (2016) 5-ALA fluorescence of cerebral metastases and its impact for the local-in-brain progression. Oncotarget 7:66776\u201366789. https:\/\/doi.org\/10.18632\/oncotarget.11488","journal-title":"Oncotarget"},{"key":"4928_CR22","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s11060-018-03066-y","volume":"141","author":"MA Kamp","year":"2019","unstructured":"Kamp MA, Munoz-Bendix C, Mijderwijk HJ, Turowski B, Dibue-Adjei M, von Sass C, Cornelius JF, Steiger HJ, Rapp M, Sabel M (2019) Is 5-ALA fluorescence of cerebral metastases a prognostic factor for local recurrence and overall survival? J Neurooncol 141:547\u2013553. https:\/\/doi.org\/10.1007\/s11060-018-03066-y","journal-title":"J Neurooncol"},{"key":"4928_CR23","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1007\/s00701-015-2479-4","volume":"157","author":"MA Kamp","year":"2015","unstructured":"Kamp MA, Rapp M, Buhner J, Slotty PJ, Reichelt D, Sadat H, Dibue-Adjei M, Steiger HJ, Turowski B, Sabel M (2015) Early postoperative magnet resonance tomography after resection of cerebral metastases. Acta Neurochir (Wien) 157:1573\u20131580. https:\/\/doi.org\/10.1007\/s00701-015-2479-4","journal-title":"Acta Neurochir (Wien)"},{"key":"4928_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13061435","author":"ST Junger","year":"2021","unstructured":"Junger ST, Pennig L, Schodel P, Goldbrunner R, Friker L, Kocher M, Proescholdt M, Grau S (2021) The debatable benefit of gross-total resection of brain metastases in a comprehensive treatment setting. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13061435","journal-title":"Cancers (Basel)"},{"key":"4928_CR25","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1200\/JCO.21.02314","volume":"40","author":"MA Vogelbaum","year":"2022","unstructured":"Vogelbaum MA, Brown PD, Messersmith H, Brastianos PK, Burri S, Cahill D, Dunn IF, Gaspar LE, Gatson NTN, Gondi V, Jordan JT, Lassman AB, Maues J, Mohile N, Redjal N, Stevens G, Sulman E, van den Bent M, Wallace HJ, Weinberg JS, Zadeh G, Schiff D (2022) Treatment for brain metastases: ASCO-SNO-ASTRO Guideline. J Clin Oncol 40:492\u2013516. https:\/\/doi.org\/10.1200\/JCO.21.02314","journal-title":"J Clin Oncol"},{"key":"4928_CR26","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1093\/neuonc\/noaa298","volume":"23","author":"E Le Rhun","year":"2021","unstructured":"Le Rhun E, Devos P, Weller J, Seystahl K, Mo F, Compter A, Berghoff AS, Jongen JLM, Wolpert F, Ruda R, Brandsma D, van den Bent M, Preusser M, Herrlinger U, Weller M (2021) Prognostic validation and clinical implications of the EANO ESMO classification of leptomeningeal metastasis from solid tumors. Neuro Oncol 23:1100\u20131112. https:\/\/doi.org\/10.1093\/neuonc\/noaa298","journal-title":"Neuro Oncol"},{"key":"4928_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/neuonc\/noac196","volume":"25","author":"K Hoang-Xuan","year":"2023","unstructured":"Hoang-Xuan K, Deckert M, Ferreri AJM, Furtner J, Gallego Perez-Larraya J, Henriksson R, Hottinger AF, Kasenda B, Lefranc F, Lossos A, McBain C, Preusser M, Roth P, Ruda R, Schlegel U, Soffietti R, Soussain C, Taphoorn MJB, Touitou V, Weller M, Bromberg JEC (2023) European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL). Neuro Oncol 25:37\u201353. https:\/\/doi.org\/10.1093\/neuonc\/noac196","journal-title":"Neuro Oncol"},{"key":"4928_CR28","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.annonc.2021.07.016","volume":"32","author":"E Le Rhun","year":"2021","unstructured":"Le Rhun E, Guckenberger M, Smits M, Dummer R, Bachelot T, Sahm F, Galldiks N, de Azambuja E, Berghoff AS, Metellus P, Peters S, Hong YK, Winkler F, Schadendorf D, van den Bent M, Seoane J, Stahel R, Minniti G, Wesseling P, Weller M, Preusser M, Board EE (2021) EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours. Ann Oncol 32:1332\u20131347. https:\/\/doi.org\/10.1016\/j.annonc.2021.07.016","journal-title":"Ann Oncol"},{"key":"4928_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2023.101624","volume":"8","author":"E Le Rhun","year":"2023","unstructured":"Le Rhun E, Weller M, van den Bent M, Brandsma D, Furtner J, Ruda R, Schadendorf D, Seoane J, Tonn JC, Wesseling P, Wick W, Minniti G, Peters S, Curigliano G, Preusser M, Committee EG (2023) Leptomeningeal metastasis from solid tumours: EANO-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. ESMO Open 8:101624. https:\/\/doi.org\/10.1016\/j.esmoop.2023.101624","journal-title":"ESMO Open"},{"key":"4928_CR30","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1200\/JCO.2016.70.1474","volume":"35","author":"BR Ferrell","year":"2017","unstructured":"Ferrell BR, Temel JS, Temin S, Alesi ER, Balboni TA, Basch EM, Firn JI, Paice JA, Peppercorn JM, Phillips T, Stovall EL, Zimmermann C, Smith TJ (2017) Integration of palliative care into standard oncology care: American society of clinical oncology clinical practice guideline update. J Clin Oncol 35:96\u2013112. https:\/\/doi.org\/10.1200\/JCO.2016.70.1474","journal-title":"J Clin Oncol"},{"key":"4928_CR31","unstructured":"Radbruch L, Andersohn F, Walker J (2015) [Palliativversorgung \u2013 Modul 3 \u2013\u00dcberversorgung kurativ\u2014Unterversorgung palliativ? Analyse ausgew\u00e4hlter Behandlungen am Lebensende]. Bertelsmann Stiftung. https:\/\/www.bertelsmann-stiftung.de\/fileadmin\/files\/BSt\/Publikationen\/GrauePublikationen\/Studie_VV__FCG_Ueber-Unterversorgung-palliativ.pdf. Accessed 22 Aug 2024"},{"key":"4928_CR32","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1007\/s00103-023-03746-9","volume":"66","author":"A Freytag","year":"2023","unstructured":"Freytag A, Meissner F, Krause M, Lehmann T, Jansky MK, Marschall U, Schmid A, Schneider N, Vollmar HC, Wedding U, Ditscheid B (2023) A regional comparison of outcomes quality and costs of general and specialized palliative care in Germany: a claims data analysis. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 66:1135\u20131145. https:\/\/doi.org\/10.1007\/s00103-023-03746-9","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"4928_CR33","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s00103-023-03683-7","volume":"66","author":"B Ditscheid","year":"2023","unstructured":"Ditscheid B, Meissner F, Gebel C, Hennig B, Marschall U, Meissner W, Wedding U, Freytag A (2023) Utilization of palliative care at the end of life in Germany: temporal trend (2016\u20132019) and regional variability. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 66:432\u2013442. https:\/\/doi.org\/10.1007\/s00103-023-03683-7","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"4928_CR34","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s11060-021-03750-6","volume":"153","author":"MA Kamp","year":"2021","unstructured":"Kamp MA, Malzkorn B, von Sass C, DiMeco F, Hadjipanayis CG, Senft C, Rapp M, Gepfner-Tuma I, Fountas K, Krieg SM, Neukirchen M, Florian IS, Schnell O, Mijderwijk HJ, Perin A, Baumgarten P, van Lieshout JH, Thon N, Renovanz M, Kahlert U, Spoor JKH, Hanggi D, McLean AL, Maurer M, Sarrubbo S, Freyschlag CF, Schmidt NO, Vergani F, Jungk C, Stein M, Forster MT, Weinberg JS, Sinclair J, Belykh E, Bello L, Mandonnet E, Moiyadi A, Sabel M (2021) Proposed definition of competencies for surgical neuro-oncology training. J Neurooncol 153:121\u2013131. https:\/\/doi.org\/10.1007\/s11060-021-03750-6","journal-title":"J Neurooncol"},{"key":"4928_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-023-05336-3","author":"I Maurer","year":"2023","unstructured":"Maurer I, Drescher R, Hammersen J, Dieckmann N, Gremme Y, Sturm MJ, McLean AL, McLean ACL, Senft C, Wittig A, Klingner C, von Sass C, Maurer M, Kamp MA (2023) Development and implementation of a student tumor board as a teaching format for medical students. J Cancer Res Clin Oncol. https:\/\/doi.org\/10.1007\/s00432-023-05336-3","journal-title":"J Cancer Res Clin Oncol"},{"key":"4928_CR36","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s41016-022-00293-1","volume":"8","author":"MA Maurer","year":"2022","unstructured":"Maurer MA, Maurer I, Kamp MA (2022) Can neuro-oncology teaching contribute to educate medical doctors better? A reflection on the value of neuro-oncology for student teaching. Chin Neurosurg J 8:23. https:\/\/doi.org\/10.1186\/s41016-022-00293-1","journal-title":"Chin Neurosurg J"},{"key":"4928_CR37","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s11060-024-04611-8","volume":"167","author":"L Fink","year":"2024","unstructured":"Fink L, van Oorschot B, von Sass C, Dibue M, Foster MT, Golla H, Goldbrunner R, Senft C, Lawson McLean A, Hellmich M, Dinc N, Voltz R, Melching H, Jungk C, Kamp MA (2024) Palliative care for in-patient malignant glioma patients in Germany. J Neurooncol 167:323\u2013338. https:\/\/doi.org\/10.1007\/s11060-024-04611-8","journal-title":"J Neurooncol"},{"key":"4928_CR38","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-023-02091-y","author":"D Schwarzkopf","year":"2023","unstructured":"Schwarzkopf D, Rose N, Fleischmann-Struzek C, Boden B, Dorow H, Edel A, Friedrich M, Gonnert FA, Gotz J, Grundling M, Heim M, Holbeck K, Jaschinski U, Koch C, Kunzer C, Le Ngoc K, Lindau S, Mehlmann NB, Meschede J, Meybohm P, Ouart D, Putensen C, Sander M, Schewe JC, Schlattmann P, Schmidt G, Schneider G, Spies C, Steinsberger F, Zacharowski K, Zinn S, Reinhart K (2023) Understanding the biases to sepsis surveillance and quality assurance caused by inaccurate coding in administrative health data. Infection. https:\/\/doi.org\/10.1007\/s15010-023-02091-y","journal-title":"Infection"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-024-04928-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-024-04928-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-024-04928-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T08:30:00Z","timestamp":1745915400000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-024-04928-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,11]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["4928"],"URL":"https:\/\/doi.org\/10.1007\/s11060-024-04928-4","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,11]]},"assertion":[{"value":"15 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers' bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript. The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}